Home » Topics » BioWorld Science

BioWorld Science
RSS

Servier and Vernalis describe USP7 inhibitors

May 6, 2020

Low-dose sorafenib shown to ameliorate NASH

May 6, 2020

Nanjing Sanhome Pharmaceutical synthesizes TGFBR1 inhibitors

May 6, 2020

Unigen divulges tyrosinase and melanin inhibitors

May 6, 2020

Rafael Pharmaceuticals and Roswell Park Comprehensive Cancer Center to evaluate CPI-613

May 6, 2020

Phase I results of bivalent CD19/CD22 CAR T cells in patients with ALL

May 6, 2020

Innovation announces new agreement to study inhibitory effects of brilacidin on SARS-CoV-2

May 6, 2020

First patients enrolled in pivotal MACOVIA study of MultiStem in COVID-19-induced ARDS

May 6, 2020

Positive topline results from global phase III INNO2VATE program of vadadustat

May 6, 2020

Model created for multiple system atrophy-C and primary progressive multiple sclerosis

May 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...